DUBLIN--(BUSINESS WIRE)--May 27, 2014--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Jefferies 2014 Global Healthcare Conference
on Monday, June 2, 2014, at 11:00 a.m. EDT (4:00 p.m. BST) from New York
City. In addition, Alkermes’ corporate presentation will be webcast live
at the Goldman Sachs 35th Annual Global Healthcare Conference
on Tuesday, June 10, 2014, at 2:40 p.m. PDT (5:40 p.m. EDT/10:40 p.m.
BST) from the Terranea Resort in Rancho Palos Verdes, Calif. These
presentations may be accessed under the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781-609-6823
Corporate
Communications
